245 related articles for article (PubMed ID: 30312275)
1. Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine.
Mazhnaya A; Marcus R; Bojko MJ; Zelenev A; Makarenko I; Pykalo I; Filippovych S; Dvoriak S; Altice FL
J Acquir Immune Defic Syndr; 2018 Nov; 79(3):288-295. PubMed ID: 30312275
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: implications for retention on opioid agonist therapy.
Kutsa O; Marcus R; Bojko MJ; Zelenev A; Mazhnaya A; Dvoriak S; Filippovych S; Altice FL
J Int AIDS Soc; 2016; 19(4 Suppl 3):20897. PubMed ID: 27435717
[TBL] [Abstract][Full Text] [Related]
3. Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study.
Kiriazova T; Go VF; Hershow RB; Hamilton EL; Sarasvita R; Bui Q; Lancaster KE; Dumchev K; Hoffman IF; Miller WC; Latkin CA
Harm Reduct J; 2020 Oct; 17(1):69. PubMed ID: 32998731
[TBL] [Abstract][Full Text] [Related]
4. Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
Makarenko I; Mazhnaya A; Marcus R; Bojko MJ; Madden L; Filippovich S; Dvoriak S; Altice FL
Int J Drug Policy; 2017 Jul; 45():56-63. PubMed ID: 28628853
[TBL] [Abstract][Full Text] [Related]
5. Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
Makarenko I; Mazhnaya A; Polonsky M; Marcus R; Bojko MJ; Filippovych S; Springer S; Dvoriak S; Altice FL
Drug Alcohol Depend; 2016 Aug; 165():213-20. PubMed ID: 27370527
[TBL] [Abstract][Full Text] [Related]
6. Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine.
Morozova O; Dvoriak S; Pykalo I; Altice FL
Drug Alcohol Depend; 2017 Apr; 173():132-138. PubMed ID: 28242537
[TBL] [Abstract][Full Text] [Related]
7. The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.
Farnum SO; Makarenko I; Madden L; Mazhnaya A; Marcus R; Prokhorova T; Bojko MJ; Rozanova J; Dvoriak S; Islam Z; Altice FL
Addiction; 2021 Jan; 116(1):83-93. PubMed ID: 32428276
[TBL] [Abstract][Full Text] [Related]
8. The role of access to integrated services at opioid agonist treatment sites in reaching 90-90-90 cascade in people who inject drugs in Ukraine: Country-level data.
Meteliuk A; Prokhorova T; Filippovych S; Ompad DC; Zaller N
Drug Alcohol Depend; 2020 Nov; 216():108216. PubMed ID: 32805547
[TBL] [Abstract][Full Text] [Related]
9. Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study.
Tan J; Altice FL; Madden LM; Zelenev A
Lancet HIV; 2020 Feb; 7(2):e121-e128. PubMed ID: 31879250
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus status awareness and test results confirmation among people who inject drugs in Ukraine.
Iakunchykova O; Meteliuk A; Zelenev A; Mazhnaya A; Tracy M; Altice FL
Int J Drug Policy; 2018 Jul; 57():11-17. PubMed ID: 29655101
[TBL] [Abstract][Full Text] [Related]
11. Utilization of buprenorphine and methadone among opioid users who inject drugs.
Tsui JI; Burt R; Thiede H; Glick SN
Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
[TBL] [Abstract][Full Text] [Related]
12. HIV treatment cascade among people who inject drugs in Ukraine.
Sazonova Y; Kulchynska R; Sereda Y; Azarskova M; Novak Y; Saliuk T; Kornilova M; Liulchuk M; Vitek C; Dumchev K
PLoS One; 2020; 15(12):e0244572. PubMed ID: 33382768
[TBL] [Abstract][Full Text] [Related]
13. Has resourcing of non-governmental harm-reduction organizations in Ukraine improved HIV prevention and treatment outcomes for people who inject drugs? Findings from multiple bio-behavioural surveys.
Trickey A; Semchuk N; Saliuk T; Sazonova Y; Varetska O; Walker JG; Lim AG; Stone J; Vickerman P
J Int AIDS Soc; 2020 Aug; 23(8):e25608. PubMed ID: 32851812
[TBL] [Abstract][Full Text] [Related]
14. The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.
Bojko MJ; Mazhnaya A; Marcus R; Makarenko I; Islam Z; Filippovych S; Dvoriak S; Altice FL
J Subst Abuse Treat; 2016 Jul; 66():37-47. PubMed ID: 27211995
[TBL] [Abstract][Full Text] [Related]
15. Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV?
Panagiotoglou D; Krebs E; Min JE; Olding M; Ahamad K; Ti L; Montaner JSG; Nosyk B
Int J Drug Policy; 2017 Sep; 47():169-176. PubMed ID: 28578865
[TBL] [Abstract][Full Text] [Related]
16. Stigma and quality of co-located care for HIV-positive people in addiction treatment in Ukraine: a cross-sectional study.
Sereda Y; Kiriazova T; Makarenko O; Carroll JJ; Rybak N; Chybisov A; Bendiks S; Idrisov B; Dutta A; Gillani FS; Samet JH; Flanigan T; Lunze K
J Int AIDS Soc; 2020 May; 23(5):e25492. PubMed ID: 32372534
[TBL] [Abstract][Full Text] [Related]
17. Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia.
Geddes L; Iversen J; Wand H; Maher L
Addiction; 2021 Mar; 116(3):525-535. PubMed ID: 32557931
[TBL] [Abstract][Full Text] [Related]
18. Assessment of barrier severity and willingness to enter opioid agonist treatment among people who inject drugs in Ukraine.
Zelenev A; Shea P; Mazhnaya A; Rozanova J; Madden L; Marcus R; Altice FL
Drug Alcohol Depend; 2018 Sep; 190():82-88. PubMed ID: 29990648
[TBL] [Abstract][Full Text] [Related]
19. Integrating methadone into primary care settings in Ukraine: effects on provider stigma and knowledge.
Bromberg DJ; Machavariani E; Madden LM; Dumchev K; LaMonaca K; Earnshaw VA; Pykalo I; Filippovych M; Haddad MS; Dvoriak S; Altice FL
J Int AIDS Soc; 2024 Feb; 27(2):e26202. PubMed ID: 38379179
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis.
Morozova O; Crawford FW; Cohen T; Paltiel AD; Altice FL
Addiction; 2020 Mar; 115(3):437-450. PubMed ID: 31478285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
